Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Buy
60
MMSI Quote, Financials, Valuation and Earnings
Last price:
$104.09
Seasonality move
:
8.82%
Day range:
$101.92 - $104.29
52-week range:
$70.70 - $111.45
Dividend yield:
0%
P/E ratio:
50.87x
P/S ratio:
4.52x
P/B ratio:
4.40x
Volume:
321.2K
Avg. volume:
689.8K
1-year change:
37.21%
Market cap:
$6.1B
Revenue:
$1.4B
EPS (TTM):
$2.03
Analysts' Opinion
-
Consensus RatingMerit Medical Systems has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $118.36, Merit Medical Systems has an estimated upside of 14.46% from its current price of $103.94.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $111.00 representing -7.49% downside risk from its current price of $103.94.
Fair Value
-
According to the consensus of 6 analysts, Merit Medical Systems has 14.46% upside to fair value with a price target of $118.36 per share.
MMSI vs. S&P 500
-
Over the past 5 trading days, Merit Medical Systems has overperformed the S&P 500 by 1.5% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Merit Medical Systems does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Merit Medical Systems has grown year-over-year revenues for 18 quarters straight. In the most recent quarter Merit Medical Systems reported revenues of $355.2M.
Earnings Growth
-
Merit Medical Systems earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Merit Medical Systems reported earnings per share of $0.46.
Enterprise value:
6.4B
EV / Invested capital:
3.05x
Price / LTM sales:
4.52x
EV / EBIT:
35.48x
EV / Revenue:
4.74x
PEG ratio (5yr expected):
2.07x
EV / Free cash flow:
35.18x
Price / Operating cash flow:
33.55x
Enterprise value / EBITDA:
21.72x
Gross Profit (TTM):
$643.3M
Return On Assets:
5.09%
Net Income Margin (TTM):
8.87%
Return On Equity:
9.36%
Return On Invested Capital:
5.83%
Operating Margin:
10.34%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.2B | $1.3B | $1.4B | $324.5M | $355.2M | |
| Gross Profit | $519.1M | $583.9M | $643.3M | $150.5M | $173M | |
| Operating Income | $101.1M | $127.5M | $156.1M | $33.1M | $36.7M | |
| EBITDA | $181.2M | $228.9M | $295.9M | $62.8M | $72.7M | |
| Diluted EPS | $1.30 | $1.63 | $2.03 | $0.48 | $0.46 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $429.7M | $482.2M | $529.1M | $1.1B | $923.8M | |
| Total Assets | $1.7B | $1.6B | $1.7B | $2.3B | $2.4B | |
| Current Liabilities | $185M | $236.3M | $220.6M | $203.6M | $216.4M | |
| Total Liabilities | $705.8M | $608.5M | $519.6M | $1.1B | $1B | |
| Total Equity | $958.6M | $1B | $1.1B | $1.2B | $1.4B | |
| Total Debt | $351.2M | $242.8M | $198M | $823M | $729.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $114.3M | $145.2M | $220.8M | $62.3M | $68.7M | |
| Cash From Investing | -$57.4M | -$175.3M | -$368.7M | -$8.3M | -$214.4M | |
| Cash From Financing | -$60.3M | $559.3M | -$60M | $472.8M | $2.4M | |
| Free Cash Flow | $66.1M | $108.5M | $182.8M | $54.5M | $64.5M | |
MMSI
Sector
Market Cap
$6.1B
$36.5M
Price % of 52-Week High
92.66%
44.66%
Dividend Yield
0%
0%
Shareholder Yield
-2.28%
-0.9%
1-Year Price Total Return
36.85%
-39.9%
Beta (5-Year)
0.914
0.774
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$103.09
200-day SMA
Buy
Level
$96.73
Bollinger Bands (100)
Buy
Level
98.64 - 106.44
Chaikin Money Flow
Buy
Level
92.9M
20-day SMA
Buy
Level
$101.60
Relative Strength Index (RSI14)
Buy
Level
54.83
ADX Line
Buy
Level
19.43
Williams %R
Neutral
Level
-27.1645
50-day SMA
Sell
Level
$104.19
MACD (12, 26)
Buy
Level
0.03
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
74.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.8419)
Buy
CA Score
(Annual)
Level (0.3063)
Buy
Beneish M-Score
(Annual)
Level (-2.4707)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.2171)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Stock Forecast FAQ
In the current month, MMSI has received 5 Buy ratings 1 Hold ratings, and 0 Sell ratings. The MMSI average analyst price target in the past 3 months is $118.36.
-
Where Will Merit Medical Systems Stock Be In 1 Year?
According to analysts, the consensus estimate is that Merit Medical Systems share price will rise to $118.36 per share over the next 12 months.
-
What Do Analysts Say About Merit Medical Systems?
Analysts are divided on their view about Merit Medical Systems share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Merit Medical Systems is a Sell and believe this share price will drop from its current level to $111.00.
-
What Is Merit Medical Systems's Price Target?
The price target for Merit Medical Systems over the next 1-year time period is forecast to be $118.36 according to 6 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is MMSI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Merit Medical Systems is a Buy. 5 of 6 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MMSI?
You can purchase shares of Merit Medical Systems via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Merit Medical Systems shares.
-
What Is The Merit Medical Systems Share Price Today?
Merit Medical Systems was last trading at $104.09 per share. This represents the most recent stock quote for Merit Medical Systems. Yesterday, Merit Medical Systems closed at $103.94 per share.
-
How To Buy Merit Medical Systems Stock Online?
In order to purchase Merit Medical Systems stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
78
AJINY alert for Mar 29
Ajinomoto [AJINY] is up 99.61% over the past day.
Buy
85
SLNO alert for Mar 29
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
69
AGX alert for Mar 29
Argan [AGX] is up 19.83% over the past day.
